)
Tenax Therapeutics (TENX) investor relations material
Tenax Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Shareholders will vote on the election of seven director nominees for the board, including June Almenoff, Michael Davidson, Declan Doogan, Christopher Giordano, Robyn Hunter, Gerald Proehl, and Stuart Rich.
Ratification of Cherry Bekaert LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is on the agenda.
The proxy may vote on other business that may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Seven individuals are nominated for election to the board, representing a mix of medical, executive, and financial expertise.
Audit committee and external auditor matters
Cherry Bekaert LLP is recommended for ratification as the independent registered public accounting firm for the next fiscal year.
- Annual meeting to elect directors, ratify auditor, and review governance and compensation.TENX
Proxy filing22 Apr 2026 - Seeks to raise up to $300 million for late-stage cardiopulmonary drug development via shelf registration.TENX
Registration filing24 Mar 2026 - LEVEL trial enrollment finished early; global expansion and Q3 results expected.TENX
Leerink Global Healthcare Conference 202610 Mar 2026 - Levosimendan targets a major unmet need in PH-HFPEF, advancing in late-stage trials.TENX
Corporate presentation10 Mar 2026 - LEVEL and LEVEL-2 trials advanced, net loss widened, cash reserves support operations through 2027.TENX
Q4 202510 Mar 2026 - Levosimendan's Phase III program advances with strong clinical data and broad market potential.TENX
Guggenheim Securities Emerging Outlook: Biotech Summit 202611 Feb 2026 - Phase 3 trials for oral levosimendan in PH-HFpEF expand, with strong funding and patent protection.TENX
Leerink’s Global Healthcare Conference 202526 Dec 2025 - Phase III oral therapy for PH-HFpEF shows promise, with strong clinical and market potential.TENX
24th Annual Needham Virtual Healthcare Conference23 Dec 2025 - Registering resale of 50M+ shares post-$100M raise to fund Phase 3 drug development.TENX
Registration Filing16 Dec 2025
Next Tenax Therapeutics earnings date
Next Tenax Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage